Clinical Intervention in Aging: Ethicolegal Issues in Assessing Risk and Benefit
Clinical interventions in aging 2010 December 2; 5: 373-80
The ethical dimension of treating the elderly, including risk-benefit analysis, focuses mainly on quality of life and end-of-life issues. These include arguments on advance directives and the concept of extraordinary treatments. This paper looks more closely at the philosophical approach to aging in order to address questions on the direction of research and issues such as longevity and social construction of the aging process. It is the way society moves to understand the value-laden choices on aging that directs the goals of treatment and research. Whilst these vary culturally, one has to reckon with a postmodern view of aging which may, in turn, reflect on the course of action of future care and research in aging. The paper canvasses how, in reality, four principles act as guidelines for moral discourse, and discusses how changing values in society decide this course of action.
Showing items related by title, author, creator and subject.
Medicare + Choice: HCFA's Actions Could Improve Plan Benefit and Appeal Information. Statement of William J. Scanlon, Director of Health Financing and Public Health Issues Testimony Before the Special Committee on Aging, U.S. Senate Unknown creator (United States. General Accounting Office [GAO], 1999-04-13)
Expectations of Benefit in Early-Phase Clinical Trials: Implications for Assessing the Adequacy of Informed Consent Weinfurt, Kevin P.; Seils, Damon M.; Tzeng, Janice P.; Compton, Kate L.; Sulmasy, Daniel P.; Astrow, Alan B.; Solarino, Nicholas A.; Schulman, Kevin A.; Meropol, Neal J. (2008-07)